Celldex Therapeutics, Inc. Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31)
Celldex Therapeutics, Inc. (CLDX) reported Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) of -$22.20 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-08.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefitContinuingOperations · last filed 2013-03-08
- Celldex Therapeutics, Inc. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2012 was -$22.20M.
- Celldex Therapeutics, Inc. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2011 was -$19.01M, a 264.91% decline from fiscal 2010.
- Celldex Therapeutics, Inc. income tax expense (benefit), continuing operations (deprecated 2013-01-31) for fiscal 2010 was $11.53M.
| Period end | Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) 12 month |
|---|---|
| 2012-12-31 | -$22.20M 10-K · filed 2013-03-08 |
| 2011-12-31 | -$19.01M 10-K · filed 2013-03-08 |
| 2010-12-31 | $11.53M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |